Ahmet Cihangir Emral1, Kürşat Dikmen4, Maryam Tahernejad2, Khotan Sardari2, Ali Rahman Pour2, Özgür Ekinci3, Mustafa Kerem4

1Department of General Surgery, Atılım University Faculty of Medicine, Ankara, Türkiye
2Atılım University Faculty of Medicine, Ankara, Türkiye
3Department of Pathology, Gazi University Faculty of Medicine, Ankara, Türkiye
4Department of General Surgery, Gazi University Faculty of Medicine, Ankara, Türkiye


Objective: The aim of this study was to compare the results of the evaluation of HPB-specific pathologists and general pathologists on the specimens of patients who underwent pancreaticoduodenectomy by the same surgical team.

Material and Methods: The pathological results of 159 patients who underwent pancreaticoduodenectomy (PD) in the periampullary region was retrospectively examined. Histopathological evaluation results of HPB-specific pathologist (S group) and other pathologists (NS group) were compared. Tumor size (mm), total lymph nodes, metastatic lymph nodes, surgical margin positive/negative (RO/R1/R2 resection) and data of patients who underwent vascular resection were evaluated.

Results: The specimens of 91 patients were examined by a HPB-specific pathologist (S group), and the specimens of 68 patients were examined by non-specific pathologists (NS group). When compared in terms of the average total number of lymph nodes and metastatic lymph nodes dissected, a statistically significant result was observed (p= 0.04, p< 0.01 respectively). Additionally, surgical margin positivity (R1) was found to be statistically higher in the S group (p= 0.02).

Conclusion: In order for the success of HPB surgery to be reflected in the clinic, it is of great importance that the specimens are examined by HPBspecific pathologists.

Keywords: Pathology, pancreaticoduodenectomy, lymph nodes, surgical margin

Cite this article as: Emral AC, Dikmen K, Tahernejad M, Sardari K, Pour AR, Ekinci Ö, et al. Histopathological evaluation after pancreatic surgery: Comparison of the results of HPB-specific pathologists and non-specific pathologists. Turk J Surg 2023; 39 (4): 310-314.


Ethics Committee Approval

This study was approved by Atılım University Medicana International Ankara Hospital Ethics Committee (Decision no: 26 Date: 26.10.2023).

Peer Review

Externally peer-reviewed.

Author Contributions

Concept - ACE, ME, KD; Design - ACE; Supervision - MK; Fundings - All authors; Data Collection and/or Processing - ACE, ÖE, ARP; Analysis and/or Interpretation - ACE, KS; Literature Search - ACE; Writing Manuscript - ACE, MT; Critical Reviews - MK.

Conflict of Interest

The authors have no conflicts of interest to declare.

Financial Disclosure

The authors declared that this study has received no financial support.